Additionally, this peptide has demonstrated its capacity to suppress radiotherapy-induced upregulation of PD-L1 and enhance the therapeutic efficacy of radiation in vivo, establishing it as a promising therapeutic agent in cancer treatment (Jin et al., 2019). This evidence concerns the gene CD274 and cancer.